BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9869395)

  • 1. Quantitative and functional analysis of core-specific T-helper cell and CTL activities in acute and chronic hepatitis B.
    Löhr HF; Krug S; Herr W; Weyer S; Schlaak J; Wölfel T; Gerken G; Meyer zum Büschenfelde KH
    Liver; 1998 Dec; 18(6):405-13. PubMed ID: 9869395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of strong hepatitis B virus (HBV) specific T helper cell and cytotoxic T lymphocyte responses by therapeutic vaccination in the trimera mouse model of chronic HBV infection.
    Böcher WO; Dekel B; Schwerin W; Geissler M; Hoffmann S; Rohwer A; Arditti F; Cooper A; Bernhard H; Berrebi A; Rose-John S; Shaul Y; Galle PR; Löhr HF; Reisner Y
    Eur J Immunol; 2001 Jul; 31(7):2071-9. PubMed ID: 11449360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of antigen-epitope-specific cytotoxic T lymphocytes in patients with hepatitis B virus infection by enzyme linked immunospot assay].
    Zhang HP; Yan HP; Zhang YH; Feng X; Zhao Y; Liao HY; Liu YM; Chen Y; Tan YF; Liu Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Aug; 43(8):690-4. PubMed ID: 20021848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dendritic cells originated from the peripheral blood in chronic hepatitis B patients can induce specific T cell immune response].
    Li RB; Chen HS; Xie Y; Fei R; Cong X; Fan CL; Wang SX; Wei L; Wang Y
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):588-91. PubMed ID: 14572332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dynamic changes and clinical significance of HBcAg18-27 specific cytotoxic T lymphocytes in acute hepatitis B patients].
    Li J; Han YP; Liu B; Liu Y; Chen N; Dong L; Yan YD; Jiang LF; Huang ZH
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):38-43. PubMed ID: 21272457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B core antigen is a potent inductor of interleukin-18 in peripheral blood mononuclear cells of healthy controls and patients with hepatitis B infection.
    Manigold T; Böcker U; Chen J; Gundt J; Traber P; Singer MV; Rossol S
    J Med Virol; 2003 Sep; 71(1):31-40. PubMed ID: 12858406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus.
    Marinos G; Torre F; Chokshi S; Hussain M; Clarke BE; Rowlands DJ; Eddleston AL; Naoumov NV; Williams R
    Hepatology; 1995 Oct; 22(4 Pt 1):1040-9. PubMed ID: 7557849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of stimulation of dendritic cell on HBV-epitopic cytotoxic T-lymphocyte].
    Zhang HH; He Y; Zhao H; Piao WH; Liu MC; Xi HL; Yu M; Wang GQ
    Zhonghua Yi Xue Za Zhi; 2005 May; 85(17):1171-6. PubMed ID: 16029590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
    Rico MA; Quiroga JA; Subirá D; Castañón S; Esteban JM; Pardo M; Carreño V
    Hepatology; 2001 Jan; 33(1):295-300. PubMed ID: 11124848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of twenty peptides representing epitopes of the hepatitis B core and surface antigens by IFN-γ response in chronic and resolved HBV.
    Brinck-Jensen NS; Vorup-Jensen T; Leutscher PD; Erikstrup C; Petersen E
    BMC Immunol; 2015 Nov; 16():65. PubMed ID: 26526193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal analysis of cytotoxic T lymphocyte precursor frequencies to the hepatitis B virus in chronically infected patients.
    Sing GK; Ladhams A; Arnold S; Parmar H; Chen X; Cooper J; Butterworth L; Stuart K; D'Arcy D; Cooksley WG
    J Viral Hepat; 2001 Jan; 8(1):19-29. PubMed ID: 11155148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic variations in precore and cytotoxic T lymphocyte regions in chronic hepatitis B in relationship to interferon responsiveness.
    Shindo M; Okuno T
    Liver; 2000 Apr; 20(2):136-42. PubMed ID: 10847482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition of Core- and Polymerase-derived immunogenic peptides included in novel therapeutic vaccine by T cells from Chinese chronic hepatitis B patients.
    Huang D; Sansas B; Jiang JH; Gong QM; Jin GD; Calais V; Yu DM; Zhu MY; Wei D; Zhang DH; Inchauspé G; Zhang XX; Zhu R
    J Viral Hepat; 2017 Nov; 24 Suppl 1():66-74. PubMed ID: 29082648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The viral clearance in interferon-treated chronic hepatitis C is associated with increased cytotoxic T cell frequencies.
    Löhr HF; Schmitz D; Arenz M; Weyer S; Gerken G; Meyer zum Büschenfelde KH
    J Hepatol; 1999 Sep; 31(3):407-15. PubMed ID: 10488697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and natural killer T (NKT) cells in patients with acute hepatitis B infection.
    Li J; Han Y; Jin K; Wan Y; Wang S; Liu B; Liu Y; Lu S; Huang Z
    Virol J; 2011 May; 8():199. PubMed ID: 21535873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between low tapasin expression and impaired CD8+ T‑cell function in patients with chronic hepatitis B.
    Tang Y; Wang J; Zhang Y; Zhuo M; Song L; Tang Z; Zang G; Chen X; Yu Y
    Mol Med Rep; 2016 Oct; 14(4):3315-22. PubMed ID: 27510296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells from chronic hepatitis B patients can induce HBV antigen-specific T cell responses.
    Li RB; Chen HS; Xie Y; Fei R; Cong X; Jiang D; Wang SX; Wei L; Wang Y
    World J Gastroenterol; 2004 Jun; 10(11):1578-82. PubMed ID: 15162529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Direct analysis of HBV-specific CD8+ lymphocyte by tetrameric HLA-A2/core 18-27 complex in chronic Hepatitis B].
    Lee CK; Suh JH; Cho YS; Han KH; Chung JB; Chon CY; Moon YM
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):139-48. PubMed ID: 12499799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances the hepatitis B virus-specific cytotoxic T-lymphocyte immune response and inhibits hepatitis B virus replication in transgenic mice.
    Zhuo M; Song L; Tang Y; Dai S; Chen X; Yu Y; Zang G; Tang Z
    Mol Med Rep; 2015 Sep; 12(3):3591-3598. PubMed ID: 26004262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of HBcAg-specific cytotoxic lymphocytes and their association with clinical status in patients with hepatitis B].
    Fan ZP; Wang FS; Xu DP; Chu FL; Shi M; Zhou Y; Zhang LX
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2073-6. PubMed ID: 15730619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.